Advanced search
Publication Cover
Leukemia & Lymphoma Volume 39, 2000 - Issue 5-6
Submit an article Journal homepage
37
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Acute Pancreatitis Associated with Interferon Alpha Therapy for Chronic Myelogenous Leukemia

Nizar M. Tannir Departments of Leukemia and Bioimmunotherapy, University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USAView further author information
,
Moshe Talpaz Departments of Leukemia and Bioimmunotherapy, University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA
,
Hassan Ghazal Departments of Leukemia and Bioimmunotherapy, University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA
,
Subhash Proothi Departments of Leukemia and Bioimmunotherapy, University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA
&
Hagop M. Kantarjian Departments of Leukemia and Bioimmunotherapy, University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USACorrespondence[email protected]
Pages 647-650 | Received 10 Jun 2000, Published online: 05 Aug 2009

References

  • Quesada J R, Talpaz M, Rios A, Kurzrock R, Gutterman J U. Clinical toxicity of interferon in cancer patients: a review. Journal of Clinical Oncology 1986; 4(2)234–243
  • McLaughlin P, Talpaz M, Quesada J, Saleem A, Barlogie B, Gutterman J U. Immune thrombocytopenia following alpha-interferon therapy in patients with cancer. JAMA 1985; 254: 1353–1354
  • Schilling P J, Kurzrock R, Kantarjian H M, Gutterman J U., Talpaz M. Development of systemic lupus erythematosus following interferon therapy in a patient with chronic myelogenous leukemia. Cancer 1991; 68(7)1536–1537
  • Sotomatsu M, Shimoda M, Ogawa C, Morikawa A. Acute pancreatitis associated with interferon a therapy for chronic myelogenous leukemia [letter]. American Journal of Hematology 1995; 48(3)211–212
  • Motoo Y. A case of acute pancreatitis induced by Interferon therapy for chronic hepatitis C. Nippon Shokakibyo Gakki Zasshi 1997; 94(8)572
  • Steinberg W, Tenner S. Acute pancrcatitis. New England J of Medicine 1994; 330: 198–1210
  • Bergholm U, Langman M, Rawlins M, et al. Drug-induced acute pancreatitis. Pharmacoepidemiol Drug Safety 1995; 4: 329–334
  • Wilmink T, Frick T W. Drug-induced pancreatitis. Drug Safety 1996; 14: 406–23
  • Graessle D, Bonacini M, Chen S. Alpha-interferon and reversible hypertriglyceridemia. Annals of Internal Medicine 1993; 118: 316–317
  • Penarrubia M J, Steegmann J L, Lavilla E, et al. Hypertriglyceridemia may be severe in CML patients treated with interferon alpha. American Journal of Hematology 1995; 49: 240–241
  • Shinohara E, Yamashita S, Kihara S, et al. Interferon alpha induces disorder of lipid metabolism by lowering post-heparin lipases and cholesteryl ester transfer protein activities in patients with chronic hepatitis C. Hepatology 1997; 25: 1502–1506
  • Eland I A, Van Puijenbrock E P, Sturkenboom M JCM, et al. Drug-associated acute pancreatitis: Twenty-one years of spontaneous reporting in the Netherlands. American Journal of Gastroenterology 1999; 94(9)2417–22
  • Sacchi S, Kantarjian H M, Cohen P, Pierce S, Talpaz M. Immune-mediated and unusual complications during alpha interferon therapy in chronic myelogenous leukemia. Journal of Clinical Oncology 1995; 13: 2401–2407
  • White C W, Sondheimer H M, Crouch E C, Wilson H, Fan L L. Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a. New England Journal of Medicine 1989; 320: 1197–1200
  • Ezekowitz R AB, Mulliken J, Folkman B. J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. New England Journal of Medicine 1992; 326: 1456–1463
  • Ravandi-Kashani F., Cortes J., Talpaz M., Kantarjian H M. Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia. Cancer 1999; 85(12)2583–2588

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.